Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Net Cash Flow (2020 - 2026)

Surrozen (SRZN) posted quarterly Net Cash Flow of $17.7 million for Q1 2026, down 73.67% year-over-year from $67.1 million in Q1 2025, and up 124.17% quarter-over-quarter from $7.9 million in Q4 2025.

Analysis

Surrozen (SRZN) Net Cash Flow (2020 - 2026) Analysis & Trends

Surrozen's Net Cash Flow history runs 7 years deep, the most recent figure standing at $17.7 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 73.67% year-over-year to $17.7 million; the TTM figure through Mar 2026 stood at $5.3 million (down 92.93% YoY), while the FY2025 annual figure was $54.7 million, up 3871.03% from the prior year.
  • Net Cash Flow for Q1 2026 stood at $17.7 million, up from $7.9 million in the prior quarter.
  • The five-year high for Net Cash Flow was $67.1 million in Q1 2025, with the low at -$18.8 million in Q1 2022.
  • The 5-year median for Net Cash Flow is $2.5 million (2022), against an average of $4.4 million.
  • The sharpest annual moves came in 2024 and 2025: Net Cash Flow slumped 383.36% in 2024, then soared 866.37% in 2025.
  • Surrozen's Net Cash Flow stood at -$836000.0 in 2022, then surged by 380.02% to $2.3 million in 2023, then jumped by 52.58% to $3.6 million in 2024, then jumped by 120.55% to $7.9 million in 2025, then soared by 124.17% to $17.7 million in 2026.
  • Business Quant data shows SRZN's Net Cash Flow at $17.7 million in Q1 2026, $7.9 million in Q4 2025, and -$9.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Surrozen 263.35 Mn 263.35 Mn - -4.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.92 Mn
Mar 31, 2026 17.66 Mn
Dec 31, 2025 7.91 Mn
Sep 30, 2025 -9.05 Mn
Jun 30, 2025 -11.24 Mn
Mar 31, 2025 67.06 Mn
Dec 31, 2024 3.55 Mn
Sep 30, 2024 -6.71 Mn
Jun 30, 2024 10.43 Mn
Mar 31, 2024 -8.75 Mn
Dec 31, 2023 2.34 Mn
Sep 30, 2023 -2.55 Mn
Jun 30, 2023 8.72 Mn
Mar 31, 2023 3.09 Mn
Dec 31, 2022 -841,000.00
Sep 30, 2022 8.68 Mn
Jun 30, 2022 2.57 Mn
Mar 31, 2022 -18.81 Mn
Dec 31, 2021 -28.01 Mn
Sep 30, 2021 42.25 Mn